company background image
BIOX logo

Bioceres Crop Solutions Informe acción NasdaqGS:BIOX

Último precio

US$6.46

Capitalización de mercado

US$399.7m

7D

-5.6%

1Y

-46.1%

Actualizada

20 Nov, 2024

Datos

Finanzas de la empresa +

Bioceres Crop Solutions Corp.

Informe acción NasdaqGS:BIOX

Capitalización de mercado: US$399.7m

Competidores de Bioceres Crop Solutions Corp.

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Bioceres Crop Solutions
Precios históricos de las acciones
Precio actual de la acciónUS$6.46
Máximo en las últimas 52 semanasUS$14.05
Mínimo de 52 semanasUS$5.71
Beta0.47
1Cambio en 1 mes-12.94%
Variación en 3 meses-34.88%
Cambio de 1 año-46.08%
3Variación en 3 años-56.82%
Variación en 5 años11.38%
Variación desde la OPV31.84%

Noticias y actualizaciones recientes

Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting

Nov 13

Recent updates

Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting

Nov 13

Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Sep 28
Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices

Sep 17

These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Aug 03
These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Rentabilidad de los accionistas

BIOXUS ChemicalsMercado US
7D-5.6%-1.1%-1.0%
1Y-46.1%9.8%30.3%

Rentabilidad vs. Industria: Los resultados de BIOX fueron inferiores a los de la industria US Chemicals, que obtuvo un rendimiento del 9.8% el año pasado.

Rentabilidad vs. Mercado: BIOX obtuvo unos resultados inferiores a los del mercado US, que fueron del 30.3% el año pasado.

Volatilidad de los precios

Is BIOX's price volatile compared to industry and market?
BIOX volatility
BIOX Average Weekly Movement6.4%
Chemicals Industry Average Movement5.4%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Precio estable de las acciones: BIOX no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de BIOX (6%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
2001n/aFederico Truccoinvestors.biocerescrops.com/home/default.aspx

Bioceres Crop Solutions Corp., junto con sus filiales, ofrece soluciones para la productividad de los cultivos. Opera a través de los segmentos de Semillas y Productos Integrados, Protección de Cultivos y Nutrición de Cultivos. El segmento de Semillas y Productos Integrados provee rasgos de semillas, germoplasmas y paquetes de tratamiento de semillas para cultivos más sanos y de mayor rendimiento.

Resumen de fundamentos de Bioceres Crop Solutions Corp.

¿Cómo se comparan los beneficios e ingresos de Bioceres Crop Solutions con su capitalización de mercado?
Estadísticas fundamentales de BIOX
Capitalización bursátilUS$399.72m
Beneficios(TTM)US$2.44m
Ingresos (TTM)US$441.23m

166.2x

Ratio precio-beneficio (PE)

0.9x

Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de BIOX
IngresosUS$441.23m
Coste de los ingresosUS$265.14m
Beneficio brutoUS$176.09m
Otros gastosUS$173.65m
BeneficiosUS$2.44m

Últimos beneficios comunicados

Sep 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)0.039
Margen bruto39.91%
Margen de beneficio neto0.55%
Ratio deuda/patrimonio72.3%

¿Cómo se ha desempeñado BIOX a largo plazo?

Ver rendimiento histórico y comparativa